Pyrimidine derivatives for the treatment of abnormal cell growth
US8722884B2 · kind B2 · utility
0Cited by
6References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 20, 2006 |
| Grant date | May 13, 2014 |
| Priority date | — |
| Expiry date | Nov 24, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to salts, solvates and substoichiometric solvates of N-[3-[[[2-[(2,3-dihydro-2-oxo-1H-indol-5-yl)amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]methyl]-2-pyridinyl]-N-methylmethanesulfonamide. The invention also provides pharmaceutical compositions comprising such complexes, as well as methods of treating abnormal cell growth by administering the complexes of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.